These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7601215

  • 1. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
    Routledge C, Gurling J, Ashworth-Preece MA, Dourish CT.
    Eur J Pharmacol; 1995 Apr 04; 276(3):281-4. PubMed ID: 7601215
    [Abstract] [Full Text] [Related]

  • 2. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB, Koek W.
    Eur J Pharmacol; 2000 Dec 08; 409(2):173-7. PubMed ID: 11104831
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.
    Routledge C, Gurling J, Wright IK, Dourish CT.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):195-202. PubMed ID: 8223894
    [Abstract] [Full Text] [Related]

  • 4. Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties.
    Assié MB, Koek W.
    Eur J Pharmacol; 1996 May 23; 304(1-3):15-21. PubMed ID: 8813579
    [Abstract] [Full Text] [Related]

  • 5. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J, Van Hest A, Van Drimmelen M, Herremans AH, Olivier B.
    Eur J Pharmacol; 1997 May 01; 325(2-3):145-53. PubMed ID: 9163561
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L, Haj-Dahmane S, Hamon M.
    Eur J Pharmacol; 1993 Nov 02; 249(1):25-35. PubMed ID: 8282017
    [Abstract] [Full Text] [Related]

  • 10. Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat.
    Assié MB, Lomenech H, Ravailhe V, Faucillon V, Newman-Tancredi A.
    Br J Pharmacol; 2006 Sep 02; 149(2):170-8. PubMed ID: 16921393
    [Abstract] [Full Text] [Related]

  • 11. Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies.
    Hjorth S, Sharp T.
    Life Sci; 1990 Sep 02; 46(13):955-63. PubMed ID: 2329921
    [Abstract] [Full Text] [Related]

  • 12. The role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--II NAN-190 and SDZ 216-525.
    Sharp T, Umbers V, Hjorth S.
    Neuropharmacology; 1996 Jun 02; 35(6):735-41. PubMed ID: 8887982
    [Abstract] [Full Text] [Related]

  • 13. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar 02; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 14. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
    O'Neill MF, Sanger GJ.
    Eur J Pharmacol; 1999 Apr 09; 370(2):85-92. PubMed ID: 10323255
    [Abstract] [Full Text] [Related]

  • 15. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG, Beneytez ME, Delgado M, Manzanares J, López-Rodríguez ML, Benhamu B, Morcillo MJ, Pozo MA, Rubia FJ, Fuentes JA.
    Pharmacology; 2001 May 09; 62(4):234-42. PubMed ID: 11360001
    [Abstract] [Full Text] [Related]

  • 16. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.
    Liu YP, Wilkinson LS, Robbins TW.
    Psychopharmacology (Berl); 2004 Apr 09; 173(1-2):175-85. PubMed ID: 14726995
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
    Sharp T, McQuade R, Bramwell S, Hjorth S.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct 09; 348(4):339-46. PubMed ID: 7904048
    [Abstract] [Full Text] [Related]

  • 20. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
    Ballarín M, Carceller A, Guitart X.
    Br J Pharmacol; 1994 Oct 09; 113(2):425-30. PubMed ID: 7530571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.